NASDAQ:MYLMylan Stock Price, Forecast & News

Mylan's stock was trading at $14.47 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, MYL stock has increased by 12.8% and is now trading at $16.32.
View which stocks have been most impacted by Coronavirus.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mylan in the last year. There are currently 5 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Mylan.

Mylan is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020.
View our earnings forecast for Mylan.

Mylan will be holding an earnings conference call on Thursday, August 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Mylan NV (NASDAQ:MYL) released its quarterly earnings data on Monday, May, 11th. The company reported $0.90 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.86 by $0.04. The firm had revenue of $2.62 billion for the quarter, compared to analysts' expectations of $2.65 billion. Mylan had a net margin of 0.54% and a return on equity of 20.00%. The business's revenue for the quarter was up 5.0% compared to the same quarter last year. During the same period in the previous year, the company earned $0.82 earnings per share.
View Mylan's earnings history.

Mylan updated its FY 2020 Pre-Market earnings guidance on Monday, May, 11th. The company provided EPS guidance of for the period. The company issued revenue guidance of $11.5-12.5 billion, compared to the consensus revenue estimate of $11.74 billion.

8 brokers have issued twelve-month price objectives for Mylan's shares. Their forecasts range from $17.00 to $27.00. On average, they anticipate Mylan's stock price to reach $20.50 in the next year. This suggests a possible upside of 25.6% from the stock's current price.
View analysts' price targets for Mylan.

News coverage about MYL stock has trended neutral recently, InfoTrie reports. The research firm identifies negative and positive media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Mylan earned a coverage optimism score of 0.4 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term.
View the latest news about Mylan.

Some companies that are related to Mylan include Johnson & Johnson (JNJ), Pfizer (PFE), Merck & Co., Inc. (MRK), Eli Lilly And Co (LLY), AbbVie (ABBV), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Royalty Pharma (RPRX), Horizon Therapeutics (HZNP), Perrigo (PRGO), Jazz Pharmaceuticals (JAZZ), Nektar Therapeutics (NKTR), Pacira Biosciences (PCRX), Corcept Therapeutics (CORT) and Zogenix (ZGNX).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Mylan investors own include Gilead Sciences (gild), Alibaba Group (BABA), Teva Pharmaceutical Industries (TEVA), Pfizer (PFE), NVIDIA (NVDA), Micron Technology (MU), Starbucks (SBUX), Intel (INTC), Cisco Systems (CSCO) and CVS Health (CVS).

Mylan trades on the NASDAQ under the ticker symbol "MYL."

Mylan's stock is owned by a variety of institutional and retail investors. Top institutional investors include Pzena Investment Management LLC (3.24%), Retirement Systems of Alabama (0.24%), First Trust Advisors LP (0.22%), SG Americas Securities LLC (0.15%), New York State Teachers Retirement System (0.14%) and State of Alaska Department of Revenue (0.08%). Company insiders that own Mylan stock include Goulds Bruce, Melina E Higgins, Paul Campbell, Richard A Mark, Robert J Coury and Sjoerd S Vollebregt.
View institutional ownership trends for Mylan.

MYL stock was sold by a variety of institutional investors in the last quarter, including Pzena Investment Management LLC, First Trust Advisors LP, Retirement Systems of Alabama, Robeco Institutional Asset Management B.V., Jabodon PT Co., Hartford Investment Management Co., Raymond James Financial Services Advisors Inc., and Zurcher Kantonalbank Zurich Cantonalbank .
View insider buying and selling activity for Mylan.

MYL stock was bought by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, SG Americas Securities LLC, DekaBank Deutsche Girozentrale, Hussman Strategic Advisors Inc., ProShare Advisors LLC, Illinois Municipal Retirement Fund, Oregon Public Employees Retirement Fund, and Foster & Motley Inc.. Company insiders that have bought Mylan stock in the last two years include Melina E Higgins, Richard A Mark, Robert J Coury, and Sjoerd S Vollebregt.
View insider buying and selling activity for Mylan.

Shares of MYL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of MYL stock can currently be purchased for approximately $16.32.

Mylan has a market capitalization of $8.44 billion and generates $11.50 billion in revenue each year. The company earns $16.80 million in net income (profit) each year or $4.42 on an earnings per share basis. Mylan employs 35,000 workers across the globe.

The official website for Mylan is www.mylan.com.

Mylan's mailing address is 1000 MYLAN BOULEVARD, CANONSBURG PA, 15317. The company can be reached via phone at 724-514-1800 or via email at [email protected]